CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle

Polish Journal of Pathology

Volumn 61, Issue 3, 2010, Pages 140-146

  Sengul, Demet ^a   Sengul, Ilker ^b   Astarci, Muzeyyen Hesna ^c   Ustun, Huseyin ^c   Mocan, Gamze ^d  

^a Prof Dr A Ilhan Ozdemir State Hospital   (Turkey)

^b GIRESUN UNIVERSITY   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cutaneous adnexal neoplasms; Differentiation; Hair follicle; Immunohistochemistry

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HAIR FOLLICLE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; SKIN CARCINOMA; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SKIN APPENDAGE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEPRILYSIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953284824     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cotton D. Troublesome tumours. 1: Adnexal tumours of the skin. J Clin Pathol 1991; 44: 543-548.
2. Weedon D, Strutton G: Tumors of cutaneous appendages. In Skin Pathology. 2nd edition. Edited by Weedon D, Strutton G. Churchill-Livingstone; New York 2002; 859-901.
3. Ackerman AB, Reddy VB, Soyer HP. Neoplasms with follicular differentiation. Ardor Scribendi, New York 2001.
4. Simpson W, Garner A, Collin JR. Benign hair-follicle derived tumours in the differential diagnosis of basal-cell carcinoma of the eyelids: a clinicopathological comparison. Br J Ophthalmol 1989; 73: 347-353.
5. Pham TT. CD10 Expression in trichoepithelioma and basal cell carcinoma. J Cutan Pathol 2006; 33: 123-128.
6. Izikson L, Bhan A, Zembowicz A. Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors. Am J Dermatopathol 2005; 27: 91-95.
7. Choi EH, Ahn SK. Hair follicul nevus. Int J Dermatol 1992; 31: 578-581.
8. Mehregan AH. Hair follicle tumors of the skin. J Cutan Pathol 1985; 12: 189-195.
9. Gray HR, Helwing HB. Trichofolliculoma. Arch Dermatol 1962; 86: 619-625.
10. Nikolowski W. [Trichoadenoma (organoid follicular hamartoma).] Arch Klin Exp Dermatol 1958; 207: 34-45.
11. Rahbari H, Mehragan A, Pinkus H. Trichoadenoma of Nikolowski. J Cutan Pathol 1977; 4: 90-98.
12. Krishna Swaroop DS, Ramakrishna BA, Bai SJ, Shanthi V. Trichoadenoma of Nikolowski. Indian J Pathol Microbiol 2008; 51: 277-279.
13. Ionescu DN, Arida M, Jukic DM. Meatstatic basal cell carcinoma. Four case reports, review of literature and immunohistochemical evalution. Arch Pathol Lab Medicine 2006; 130: 45-51.
14. Miller SJ. Aethiology and pathogenesis of basal cell carcinoma. Clin Dermatol 1995; 13: 527-536.
15. Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth, et al. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2007; 157 Suppl 2: 47-51.
16. Leffel DJ, Fitzgeral DA. Basal cell carcinoma. Fitzpatrick's Dermatology in General Medicine. Freadberg IM, Eisen AZ. Wolff K, Auston KF, Goldsmith LA, Katz SI, Fitzpatrick TB. McGraw Hill 1999; 1: 857-864.
17. Murphy GF, Elder DE. Basal cell carcinoma. In: Atlas of Tumour Pathology. Non-melanocytic Tumours of the Skin. Washington, DC: Armed Forced Institude of Pathology 1990; 47-60.
18. Lear JT, Harvey I, de Berker D, et al. Basal cell carcinoma. J R Soc Med 1998; 91: 585-588.
19. Brenn T, McKee PH. Tumors of the surface epithelium. In: Patholoy of The Skin. McKee PH, Calonje E, Granter SR (eds.) Vol. 2 Elsevier Mosby, Philadelphia. 2005; 1167-1184.
20. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 2003; 148: 195-202.
21. McIntosh GG, Lodge AJ, Watson P, et al. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in parffinembedded tissue. Am J Pathol 1999; 154: 77-82.
22. Sezaki N, Ishimaru F, Tabayashi T, et al. The type 1 CD10/neutral endopeptidase 24.11 promoter: functional characterization of the 5'-untranslated region. Br J Haematol 2003; 123: 177-183.
23. Knapp W, Lutz D, Bettelheim P. et al. Diagnostic specificity of the monoclonal anti-CALLA antibody VIL-A1 in leukemia and malignant lymphoma. Med Oncol Tumor Pharmacother 1984; 1: 25-32.
24. Dong HY, Gorczyca W, Liu Z, et al. B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol 2003; 119: 218-230.
25. Kanitakis J, Bourchany D, Claudy A. Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin. Anticancer Res 2000; 20(5B): 3539-3544.
26. Kanitakis J, Narvaez D, Claudy A. Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin. Melanoma Res 2002; 12: 241-244.
27. Carr RA, Taibjee SM, Sanders DSA. Basolid skin tumors: basal cell carcinoma. Current Diagnostic Pathol 2007; 13: 252-272.
28. Carr RA, Sanders DSA. The use of immunohistochemistry in the differential diagnosis of common epithelial tumors of the skin. Current Diagnostic Pathol 2007; 13: 237-251.
29. Kirchmann TT, Prieto VG, Smoller BR. CD34 staining pattern distinguishes basal cell carcinoma from trichoepitelioma. Arch Dermatol 1994; 130: 589-592.
30. Bahrami S, Malone JC, Lear S, et al. CD10 expression in cutaneous adnexal neoplasms and a potential role for differentiating cutaneous metastatic renal cell carcinoma. Arch Pathol Lab Med 2006; 130: 1315-1319.
31. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms.Freguent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol 2000; 113: 374-382.
32. Yada K, Kashima K, Daa T, et al. Expression of CD10 in basal cell carcinoma. Am J Dermatopathol 2004; 26: 463-471.
33. Ogawa H, Iwaya K, Izumi M. Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002; 33: 806-811.
34. Iwaya K, Ogawa H, Izumi M. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 2002; 440: 589-593.
35. Schirren CG, Rütten A, Kaudewitz P, et al. Trichoblastoma and basal cell carcinoma are neoplasms with follicular difeferentiation sharing the same profile of cytokeratin intermediate filaments. Am J of Dermatopathol 1997; 19: 341-350.
36. Hjalmar K, Lorenz E. Cytokeratins as markers of follicular differentiation. Am J Dermatopathol 2001; 23: 501-509.
37. Ramos-Ceballos FI, Pashaei S, Kincannon JM, et al. Blc-2, CD34 and CD10 expression in basaloid follicular hamartoma, vellus hair hamartoma and neurofollicular hamartoma demonstrate full follicular differentiation. J Cutan Pathol 2008; 35: 477-483.
38. Costache M, Bresh M, Böer A. Desmoplastic trichoepitelioma versus morpheic basal cell crcinoma:a critical reappraisal of histomorphological and immunohistochemical criteria for diffrentiation. Histopathology 2008; 52: 865-876.
39. Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, et al. Immunochemical evaluation of basal cell carcinoma using Bcl-2, Ki67, PCNA and P53. J Cutan Pathol 2000; 27: 169-175.